Feasibility of utilizing a novel mhealth platform to deliver an evidence-based exercise intervention among testicular cancer survivors (TCS).
Chunkit Fung(Oslo University Hospital), Karen M. Mustian(University of Rochester Medical Center), Eugene Storozynsky(University of Rochester Medicine), Charles E. Heckler(University of Rochester Medicine), Michelle Porto(University of Rochester), Jennifer L. Peckham(University of Rochester), Michelle C. Janelsins(University of Rochester), Bonnie Ky(Virginia Commonwealth University), Elizabeth A. Guancial(Harvard University), Eva Culakova(University of Rochester), Lauren B. Bruckner(University of Rochester Medicine), Supriya G. Mohile(University of Rochester Medical Center), Po Lin Lin(University of Rochester), Deepak M. Sahasrabudhe(University of Rochester Medical Center)
Cited by 2
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
|New England Journal of Medicine|2006|873
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589